About Index Trending news
Analyze
Top 50 Pricing
Proximagen

Proximagen

Work at Proximagen? Add yourself to this profile

Proximagen

Proximagen Group plc (AIM:PRX) is focused on the development and commercialisation of novel therapeutics for diseases of the central nervous system.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
$16,000,000
Employees

Unknown size

Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Proximagen makes some noise.